Identification and validation of cerebral KCa3.1/KCa2.3 potassium channels a drug tragets for the prevention and treatment of cerebral ischemia associated with diabetes and Alzheimers disease

Projektinformationen

BRAINIK

ID Finanzhilfevereinbarung: 321721

Projekt abgeschlossen

Startdatum 1 Oktober 2012

Enddatum 30 September 2016

Finanziert unter

• Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Gesamtkosten € 100 000,00

EU-Beitrag € 100 000,00

Koordiniert durch

INSTITUTO ARAGONES DE CIENCIAS DE LA SALUD
Spain